Skip to main content
A desk with printed WATCHMAN resources and a laptop with the WATCHMAN site on the screen.

Referrer download center

Access downloadable tools and educational resources to support the referral process. 
 

WATCHMAN referral support: Educational tools and resources for referring healthcare professionals

WATCHMAN referring healthcare professional brochure


Download the referring healthcare brochure for information on the WATCHMAN Implant, indications and patient eligibility, and more.


 

OAC Risks One-Pager


Download this one-pager to learn more about oral anticoagulant (OAC) usage risks associated with adherence issues, polypharmacy and long-term use.


 

WATCHMAN Stroke Awareness One-Pager


Learn key data supporting WATCHMAN as an alternative solution for reducing atrial fibrillation (AFib)-related stroke risk.


 

Patient screening and referral form


Download this patient screening tool to help you determine which AFib patients are potential candidates for the WATCHMAN Implant and connect them with an implanter for consultation.


 

Combined Procedure Brochure


Download the referring healthcare professional brochure outlining the features and patient benefits for concomitant ablation and left atrial appendage closure (LAAC) procedures. 


 

WATCHMAN referring pocket guide


Download this quick reference guide on WATCHMAN patient eligibility, procedure overview, safety and efficacy, and patient cost.


 

Shared decision-making brochure


Shared decision making is a collaborative process that allows you and your patients to make healthcare treatment decisions together. Download the brochure to learn more about shared decision making for LAAC therapy.


 

Screenshot of WATCHMAN AFib guidelines postcard

WATCHMAN AFib guidelines postcard


In 2023, Left Atrial Appendage Occlusion (LAAO) devices were upgraded to a 2a class of recommendation for patients with a contraindication to long-term OACs. Download the postcard to learn more about the upgrade, view the updated guidelines, and understand which patients may benefit from an LAAO device like WATCHMAN.


 

WATCHMAN IFU label change post-implant drug regimen postcard


The FDA has approved updates to the WATCHMAN FLX Pro LAAC Implant Instructions for Use (IFU), reflecting findings from the OPTION clinical trial and SURPASS study. Download the postcard for more details. 


 

How To Create WATCHMAN Therapy Awareness


Guide to create an actionable market education program. Leverage materials from Boston Scientific and partner with your Boston Scientific rep to create a plan to raise awareness for stroke risk reduction and to educate all stakeholders about the WATCHMAN Implant device in your area.


 


 

Find a WATCHMAN implanter near you